vs
Apple Hospitality REIT, Inc.（APLE）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Apple Hospitality REIT, Inc.的季度营收约是Ultragenyx Pharmaceutical Inc.的1.6倍（$326.4M vs $207.3M），Apple Hospitality REIT, Inc.净利率更高（9.1% vs -62.0%，领先71.1%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -2.0%），Apple Hospitality REIT, Inc.自由现金流更多（$282.0M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -0.5%）
莱曼 hospitality properties是一家深耕酒店、度假村、娱乐及媒体领域的企业，得名于旗下核心资产——位于田纳西州纳什维尔的国家历史地标莱曼礼堂。公司历史可追溯至曾作为爱德华·盖洛德旗下俄克拉荷马出版公司子公司的时期，1983年收购WSM公司后，拿下大奥普里等知名IP，奠定了如今的业务发展基础。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
APLE vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $326.4M | $207.3M |
| 净利润 | $29.6M | $-128.6M |
| 毛利率 | 37.2% | — |
| 营业利润率 | 15.2% | -54.7% |
| 净利率 | 9.1% | -62.0% |
| 营收同比 | -2.0% | 25.9% |
| 净利润同比 | -0.7% | 3.5% |
| 每股收益（稀释后） | $0.13 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $326.4M | $207.3M | ||
| Q3 25 | $373.9M | $159.9M | ||
| Q2 25 | $384.4M | $166.5M | ||
| Q1 25 | $327.7M | $139.3M | ||
| Q4 24 | $333.0M | $164.6M | ||
| Q3 24 | $378.8M | $139.5M | ||
| Q2 24 | $390.1M | $147.0M | ||
| Q1 24 | $329.5M | $108.8M |
| Q4 25 | $29.6M | $-128.6M | ||
| Q3 25 | $50.9M | $-180.4M | ||
| Q2 25 | $63.6M | $-115.0M | ||
| Q1 25 | $31.2M | $-151.1M | ||
| Q4 24 | $29.8M | $-133.2M | ||
| Q3 24 | $56.3M | $-133.5M | ||
| Q2 24 | $73.9M | $-131.6M | ||
| Q1 24 | $54.0M | $-170.7M |
| Q4 25 | 37.2% | — | ||
| Q3 25 | 40.6% | — | ||
| Q2 25 | 42.6% | — | ||
| Q1 25 | 39.0% | — | ||
| Q4 24 | 38.6% | — | ||
| Q3 24 | 41.9% | — | ||
| Q2 24 | 44.6% | — | ||
| Q1 24 | 40.1% | — |
| Q4 25 | 15.2% | -54.7% | ||
| Q3 25 | 19.4% | -106.9% | ||
| Q2 25 | 22.1% | -64.8% | ||
| Q1 25 | 15.5% | -102.6% | ||
| Q4 24 | 15.0% | -74.3% | ||
| Q3 24 | 20.5% | -94.6% | ||
| Q2 24 | 24.0% | -79.1% | ||
| Q1 24 | 21.7% | -151.9% |
| Q4 25 | 9.1% | -62.0% | ||
| Q3 25 | 13.6% | -112.8% | ||
| Q2 25 | 16.6% | -69.0% | ||
| Q1 25 | 9.5% | -108.5% | ||
| Q4 24 | 9.0% | -80.9% | ||
| Q3 24 | 14.9% | -95.7% | ||
| Q2 24 | 19.0% | -89.5% | ||
| Q1 24 | 16.4% | -156.8% |
| Q4 25 | $0.13 | $-1.28 | ||
| Q3 25 | $0.21 | $-1.81 | ||
| Q2 25 | $0.27 | $-1.17 | ||
| Q1 25 | $0.13 | $-1.57 | ||
| Q4 24 | $0.13 | $-1.34 | ||
| Q3 24 | $0.23 | $-1.40 | ||
| Q2 24 | $0.31 | $-1.52 | ||
| Q1 24 | $0.22 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.5M | $421.0M |
| 总债务越低越好 | $1.5B | — |
| 股东权益账面价值 | $3.1B | $-80.0M |
| 总资产 | $4.9B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.49× | — |
8季度趋势，按日历期对齐
| Q4 25 | $8.5M | $421.0M | ||
| Q3 25 | $50.3M | $202.5M | ||
| Q2 25 | $7.9M | $176.3M | ||
| Q1 25 | $14.9M | $127.1M | ||
| Q4 24 | $10.3M | $174.0M | ||
| Q3 24 | $6.1M | $150.6M | ||
| Q2 24 | $7.2M | $480.7M | ||
| Q1 24 | $4.9M | $112.3M |
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.5B | — | ||
| Q1 24 | $1.5B | — |
| Q4 25 | $3.1B | $-80.0M | ||
| Q3 25 | $3.2B | $9.2M | ||
| Q2 25 | $3.2B | $151.3M | ||
| Q1 25 | $3.2B | $144.2M | ||
| Q4 24 | $3.3B | $255.0M | ||
| Q3 24 | $3.3B | $346.8M | ||
| Q2 24 | $3.3B | $432.4M | ||
| Q1 24 | $3.3B | $140.3M |
| Q4 25 | $4.9B | $1.5B | ||
| Q3 25 | $4.9B | $1.2B | ||
| Q2 25 | $4.9B | $1.3B | ||
| Q1 25 | $4.9B | $1.3B | ||
| Q4 24 | $5.0B | $1.5B | ||
| Q3 24 | $5.0B | $1.5B | ||
| Q2 24 | $5.1B | $1.6B | ||
| Q1 24 | $5.0B | $1.3B |
| Q4 25 | 0.49× | — | ||
| Q3 25 | 0.47× | — | ||
| Q2 25 | 0.48× | — | ||
| Q1 25 | 0.48× | — | ||
| Q4 24 | 0.45× | — | ||
| Q3 24 | 0.46× | — | ||
| Q2 24 | 0.46× | — | ||
| Q1 24 | 0.45× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $370.2M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $282.0M | $-100.8M |
| 自由现金流率自由现金流/营收 | 86.4% | -48.6% |
| 资本支出强度资本支出/营收 | 27.0% | 0.5% |
| 现金转化率经营现金流/净利润 | 12.50× | — |
| 过去12个月自由现金流最近4个季度 | $516.8M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $370.2M | $-99.8M | ||
| Q3 25 | $126.4M | $-91.4M | ||
| Q2 25 | $108.8M | $-108.3M | ||
| Q1 25 | $49.1M | $-166.5M | ||
| Q4 24 | $405.4M | $-79.3M | ||
| Q3 24 | $128.2M | $-67.0M | ||
| Q2 24 | $127.3M | $-77.0M | ||
| Q1 24 | $54.7M | $-190.7M |
| Q4 25 | $282.0M | $-100.8M | ||
| Q3 25 | $109.0M | $-92.7M | ||
| Q2 25 | $96.2M | $-110.7M | ||
| Q1 25 | $29.5M | $-167.8M | ||
| Q4 24 | $327.1M | $-79.5M | ||
| Q3 24 | $113.1M | $-68.6M | ||
| Q2 24 | $115.0M | $-79.0M | ||
| Q1 24 | $34.4M | $-193.9M |
| Q4 25 | 86.4% | -48.6% | ||
| Q3 25 | 29.2% | -58.0% | ||
| Q2 25 | 25.0% | -66.5% | ||
| Q1 25 | 9.0% | -120.5% | ||
| Q4 24 | 98.2% | -48.3% | ||
| Q3 24 | 29.9% | -49.2% | ||
| Q2 24 | 29.5% | -53.7% | ||
| Q1 24 | 10.4% | -178.2% |
| Q4 25 | 27.0% | 0.5% | ||
| Q3 25 | 4.7% | 0.8% | ||
| Q2 25 | 3.3% | 1.5% | ||
| Q1 25 | 6.0% | 1.0% | ||
| Q4 24 | 23.5% | 0.1% | ||
| Q3 24 | 4.0% | 1.2% | ||
| Q2 24 | 3.2% | 1.4% | ||
| Q1 24 | 6.2% | 3.0% |
| Q4 25 | 12.50× | — | ||
| Q3 25 | 2.49× | — | ||
| Q2 25 | 1.71× | — | ||
| Q1 25 | 1.57× | — | ||
| Q4 24 | 13.59× | — | ||
| Q3 24 | 2.28× | — | ||
| Q2 24 | 1.72× | — | ||
| Q1 24 | 1.01× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLE
| Occupancy | $293.0M | 90% |
| Hotel Other | $17.2M | 5% |
| Food And Beverage | $16.3M | 5% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
